DK0777498T3 - Konjugater fremstillet af metalkomplekser og oligonucleotider - Google Patents

Konjugater fremstillet af metalkomplekser og oligonucleotider

Info

Publication number
DK0777498T3
DK0777498T3 DK95925792T DK95925792T DK0777498T3 DK 0777498 T3 DK0777498 T3 DK 0777498T3 DK 95925792 T DK95925792 T DK 95925792T DK 95925792 T DK95925792 T DK 95925792T DK 0777498 T3 DK0777498 T3 DK 0777498T3
Authority
DK
Denmark
Prior art keywords
oligonucleotides
metal complexes
complex
bound
complexing agent
Prior art date
Application number
DK95925792T
Other languages
Danish (da)
English (en)
Inventor
Ulrich Niedballa
Ulrich Speck
Johannes Platzek
Bernd Raduechel
Ludger Dinkelborg
Larry Gold
Wolfgang Pieken
Christoph-Stephan Hilger
Original Assignee
Schering Ag
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25938359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0777498(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4424922A external-priority patent/DE4424922A1/de
Priority claimed from DE19944445078 external-priority patent/DE4445078A1/de
Application filed by Schering Ag, Nexstar Pharmaceuticals Inc filed Critical Schering Ag
Application granted granted Critical
Publication of DK0777498T3 publication Critical patent/DK0777498T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK95925792T 1994-07-14 1995-06-30 Konjugater fremstillet af metalkomplekser og oligonucleotider DK0777498T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4424922A DE4424922A1 (de) 1994-07-14 1994-07-14 Konjugate aus Metallkomplexen und Oligonucleotiden, die spezifisch an bestimmte Zielstrukturen binden
DE19944445078 DE4445078A1 (de) 1994-12-05 1994-12-05 Konjugate aus Metallkomplexen und Oligonucleotiden, diese enthaltende Mittel, deren Verwendung in der Radiodiagnostik sowie Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
DK0777498T3 true DK0777498T3 (da) 2004-08-16

Family

ID=25938359

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95925792T DK0777498T3 (da) 1994-07-14 1995-06-30 Konjugater fremstillet af metalkomplekser og oligonucleotider

Country Status (23)

Country Link
EP (1) EP0777498B1 (cs)
JP (2) JPH10503182A (cs)
KR (1) KR100366525B1 (cs)
CN (1) CN1219551C (cs)
AT (1) ATE265229T1 (cs)
AU (1) AU2979195A (cs)
CA (1) CA2194558A1 (cs)
CZ (1) CZ295930B6 (cs)
DE (1) DE69532958T2 (cs)
DK (1) DK0777498T3 (cs)
ES (1) ES2220933T3 (cs)
HU (1) HU220859B1 (cs)
IL (1) IL114237A (cs)
MX (1) MX9606443A (cs)
NO (1) NO318585B1 (cs)
NZ (1) NZ289831A (cs)
PL (1) PL318147A1 (cs)
PT (1) PT777498E (cs)
RU (1) RU2165771C2 (cs)
SK (1) SK284598B6 (cs)
TW (1) TW502040B (cs)
UA (1) UA48140C2 (cs)
WO (1) WO1996002274A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2259493A1 (en) * 1996-07-03 1998-01-08 President And Fellows Of Harvard College Oligonucleotide linker and techniques involving immobilized and linked oligonucleotides
US6335437B1 (en) * 1998-09-07 2002-01-01 Isis Pharmaceuticals, Inc. Methods for the preparation of conjugated oligomers
JP2009535383A (ja) * 2006-05-03 2009-10-01 バルティック テクロノジー デヴェロプメント，リミテッド 強く結合した塩基で修飾されたオリゴヌクレオチドと人工ヌクレアーゼを組み合わせたアンチセンス作用物質
GB201012418D0 (en) * 2010-07-23 2010-09-08 Santaris Pharma As Process
KR101948404B1 (ko) 2014-05-13 2019-02-14 폴 슈레 앙스띠뛰 양전자 방출 단층촬영에 사용하기 위한 43sc 방사성핵종 및 그의 방사성제약의 제조

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013831A (en) * 1984-01-30 1991-05-07 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
JP2785025B2 (ja) * 1985-03-19 1998-08-13 ランデル・エル・ミルズ 診断と選択的組織壊死を与える装置
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
WO1989000062A1 (en) * 1987-07-07 1989-01-12 The Cancer Institute Board Radiotherapy
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
EP1493825A3 (en) * 1990-06-11 2005-02-09 Gilead Sciences, Inc. Method for producing nucleic acid ligands
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
IE914220A1 (en) * 1990-12-10 1992-06-17 Akzo Nv Labelled, modified oligonucleotides
EP0588229A3 (en) * 1992-09-12 1994-06-15 Hoechst Ag Macrocyclic chelating agents for the preparation of technetium or rhenium complexes

Also Published As

Publication number Publication date
DE69532958T2 (de) 2009-04-09
PT777498E (pt) 2004-09-30
EP0777498A1 (en) 1997-06-11
KR970704471A (ko) 1997-09-06
JPH10503182A (ja) 1998-03-24
RU2165771C2 (ru) 2001-04-27
TW502040B (en) 2002-09-11
NO970141D0 (no) 1997-01-13
CZ11497A3 (cs) 1998-08-12
UA48140C2 (uk) 2002-08-15
ATE265229T1 (de) 2004-05-15
HU9700100D0 (en) 1997-02-28
JP2009197024A (ja) 2009-09-03
IL114237A0 (en) 1995-10-31
IL114237A (en) 2000-08-31
CZ295930B6 (cs) 2005-12-14
MX9606443A (es) 1997-12-31
KR100366525B1 (ko) 2003-03-15
CN1152879A (zh) 1997-06-25
SK284598B6 (sk) 2005-07-01
EP0777498B1 (en) 2004-04-28
NO970141L (no) 1997-03-14
HU220859B1 (en) 2002-06-29
PL318147A1 (en) 1997-05-12
NO318585B1 (no) 2005-04-11
NZ289831A (en) 1999-01-28
CN1219551C (zh) 2005-09-21
WO1996002274A1 (en) 1996-02-01
ES2220933T3 (es) 2004-12-16
SK2897A3 (en) 1997-09-10
DE69532958D1 (de) 2004-06-03
AU2979195A (en) 1996-02-16
CA2194558A1 (en) 1996-02-01
HUT76329A (en) 1997-08-28

Similar Documents

Publication Publication Date Title
ATE228361T1 (de) Reduzierung der kardiotoxizität von antitumormitteln mit manganverbindungen
DK0871649T3 (da) Konjugater af et polypeptid og en biokompatibel polymer
MXPA02010801A (es) Agentes diagnosticos, de representacion y terapeuticos cationicos asociados con sitios vasculares activados.
DE69514350D1 (de) Gallensäurekonjugate, ihre metallkomplexe und verwandte verwendungen
NO166267C (no) Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet.
ATE120457T1 (de) Macrocyclische bifunktionelle chelatbildner, komplexe davon und ihre konjugierten antikörper.
DK0841949T3 (da) Anvendelse af saccharid-konjugater
WO1999059640A3 (en) Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
DK1242115T3 (da) Kemisk programmerbar immunitet
ES2109495T3 (es) Tioureas sustituidas utilizadas como agentes quelantes bifuncionales.
EP2112165A3 (en) Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
TR200003161T2 (tr) Poliol-IFN-Beta konjugatları
WO2001076645A3 (en) Targeted agents useful for diagnostic and therapeutic applications
CA2001765A1 (en) Chelants possessing ortho ligating functionality and complexes thereof
DK0777498T3 (da) Konjugater fremstillet af metalkomplekser og oligonucleotider
WO2000013712A3 (en) Methods and compositions for the prevention or treatment of cancer
WO1996040273A3 (en) Conjugates of ferrites and oligonucleotides, which bond specifically to certain target structures
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
EP1234585A3 (en) Methods and compositions for the prevention or treatment of cancer